Wayne State Imlv. Detroit A ten month old Infant wlth multlple Reye Syndrome-llke attacks excreted during the illness p-hydro&but;ate,acetoacetate and large m u n t s of the following dicarboxylic acids: adipate, suberate,sebacate, ethylmalonate and g1utarate.Prcduction of C02 fm(1-14C) and(~-14~)~almitate and(1-14~)butyrate was 83%, 5% and 508, respectively. Acyl-CoA dehydrogenase was normal. Riboflavin therapy eliminated the dicarboxylic aciduria under ordinary load conditions. Carnitine metailism was studied because plasma carnitine was low (22.2 pnl/l) and continued to decrease despite the apparent beneficial effect of riboflavin.Urinary free and short chain acylcarnitines(SCAC)were initially 17.land 108.9,ml/l(N:24.2 and 38.9),suggesting that hypocarnitinemia was due to urinary SCAC-loss(86-96% of total) although absolute losses (227 pnl/g cr)were only mildly elevated. Urine values normalized during i.v. glucose. After recovery from the attack and from dicarboxylic aciduria under riboflavin therapy, oral carnitine was given. This unveiled the persistence of the underlying defect, because SCAC excretion increased to 994 pnDl/g cr.
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Regulation of glu;?onebgenesis has been studied i n 4-baboon fetuses (135-140 d.) with catheters chronically placed i n the inferior vena cava and aorta, using a single isotope-labeled precursor technique. A primed infusion of [ u -1 4~1 lactate (Lac) was administered t o the fetus t o steady state over 150 min. Net Lac t o glucose (Glu) conversion was evaluated by comparing fetal (Fet) and Maternal (Mat) dpm and specific activitv (s.A.) of Lac and Glu durina Mat fed (4). fasting (4), and Glu infusion (1) JM was a 1928 gram, 36-week small for gestation age male infant born to a Grav.-111, Para-0 mother. Wyperglycemia of 340 mg % was identified on arrival to the nursery. Conventional approach changing from regular to NPH insulin proved unsatisfactory. Thus regular S.C. insulin (U20) was administered every 3 hrs pre-formula feeding based on Glucometer blood heel stick glucose using a sliding scale insulin dosage of 0.1 to 0.5 units. Pen-Pump (U20 regular insulin) was utilized with manual administered pre-meal doses. Insulin syringes were refilled every 12 to 24 hrs and needle sites changed every 2 to 3 days. A trial on CPI Mode19100 ambulatory infusion pump was shown feasible with continuous insulin of 3 units124 hr rate (UlO insulin). JM was discharged at 1 month of age on a Pen-Pump with home glucose monitoring pre-meals and sliding dose regular insulin. An infusion site staph aureus cellulitis resulted in rehospitalization. A new trial of NPH (U10) To enable linkage studies DNAs from the 10 parents were digested w i t h 12 d i f f e r e n t r e s t r i c t i o n endonucleases.
Only a f t e r I d i g e s t i o n was a v a r i a t i o n seen (23,15.5 and 13 kb bands i n some versus 23 kb i n others). Using a smaller human CPS cDNA we detected three patterns 23, 23+13 and 13 kb. I n one f a m i l y both parents had t h e 23+13, 2 affected sibs had only the 23 and a normal s i b had only the 13 kb fragment(s) i n agreement w i t h simple Mendelian inheritance. I n 2 other f a m i l i e s the a f f e c t e d had only the 23 kb fragment.
The affected c h i l d r e n i n the remaining 2 f a m i l i e s had 23+13 o r 13 kb patterns.
Our studies suggest t h a t 1) l a r g e deletions o r i n s e r t i o n s o f the CPS genes were n o t detected; 2) the CPSD phenotype and the I derived r e s t r i c t i o n fragments co-segregate and 3) genetic heterogeneity e x i s t s i n CPSD. 
Growth f a i i u r e i n 4 h y p e r c a l c i u r i a have been noted independ e n t l y i n c h i l d r e n w i t h i n s u l in-dependent diabetes me1 1 i t u s (IDDM). Ue evaluated growth and calcium metabolism i n 175 IDDM c h i l d r e n and 38 non-diabetic (ND) sibs o f s i m i l a r ages. Height
was determined by 2 o f t h e authors using a Stadiometer. Blood and u r i n e were c o l l e c t e d i n t h e A M before food and i n s u l i n had been ~e r c e n t i l e tX.05). Ca/Cr correlated w i t h coincident serum alucose b . 2 8 p<.0002, H~A~, r=.24 p<.0004, but not w i t h serum ~a,-a1 kal i n e phosphatase, vitamin 0 o r PTH. Ca/Cr c o r r e l a t e d i n v e r s e l y w i t h Ht p e r c e n t i l e r=.20 p<.01. IDDM w i t h Ca/Cr>ND range were s h o r t e r 37~3.2 p e r c e n t i l e than ND 54t3.8 p e r c e n t i l e p<.01. Hyp e r c a l c i u r i a was associated w i t h both poor glycemic control and growth f a i l u r e i n IDDM children. When coincident serum glucose, HbAlc and duration o f IDDM a r e factored out o f t h e analysis o f variance t h e Ca/Cr continues t o have a negative c o r r e l a t i o n t o height p e r c e n t i l e . Hypercalciuria appears t o be an important fact o r i n the growth f a i l u r e associated w i t h IODM. Sulfonylureas potentiate the cellular action of insulin, not by changing membrane receptor number as previously thought, but by unknown postbinding mechanisms. We investigated the direct effects of tolazamide on fatty acid oxidation in isolated intact liver mitochondria, prepared from fed and fasted rats. Total ketone body formation and C02 production (210% of total oxidative products) were measured using l-14c palmitate. Ketoketone formation (data not shown). Onlv mitochondria from fed genesis results are expressed in nmolslmin/mg prot. (+ SEM).
INHIBITION OF FATTY ACID
.004 .04 .4 4 40 rats were sensitive to tolazamide inhibition of fatty acid oxidation; this was dose dependent with a maximum attenuation at 4vg/ml. Carnitine acyltransferase activity was unaffected by high dose tolazamide. In the absence of insulin, sulfonylureas, at levels below therapeutic (20-40ug/ml), attenuate fatty acid oxidation in hepatic mitochondria from fed rats. This inhibition occurs proximal to acetyl CoA formation; perhaps these compounds are related to or intensify a putative insulin mediator released after receptor occupation. 
